Diagnosis and Treatment of Endometrial Cancer
Submission Deadline: 30 Jun 2023
Guest Editor
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology Catholic University of the Sacred Heart, Policlinico Agostino Gemelli IRCCS Largo A. Gemelli 8, Rome, Italy
Interests: laparoscopic; gynecologic oncology; surgery; laparoscopic surgery; minimally invasive surgery
Special Issue Information
Dear Colleagues,
Endometrial cancer (EC) is the most widespread gynecologic malignancy in industrialized nations. Unlike other gynecological malignancies, its incidence and mortality are increasing globally; the incidence of EC in the United States is expected to double by 2030. Generally, EC is diagnosed at an early stage with favorable prognosis; in most cases, surgery represents the mainstay of treatment. However, about 20% of early-stage EC patients present poor outcomes due to the presence of several well-defined histologic risk factors. The rising tendency toward a more personalized diagnosis, surgical approach, adjuvant therapy and oncological surveillance, have suggested the need to develop new and molecular-integrated protocols to manage the endometrial cancer.
The aim of this Special Issue is to provide novel insight into the diagnosis and treatment of endometrial cancer.
Dr. Emanuele Perrone
Guest Editor
Keywords
- endometrial cancer
- surgical approach
- diagnosis
- fertility sparing treatment
- personalized approach
- molecular classification
- robotic surgery
- minimally invasive approach
- chemotherapy
- radiotherapy
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (4)
Prognostic Role of Lymphadenectomy among Women with Low Grade Lymphovascular Space Invasion-Positive Clinically Uterus Confined Endometrioid Endometrial Cancer
Clin. Exp. Obstet. Gynecol. 2023, 50(12), 270; https://doi.org/10.31083/j.ceog5012270
(This article belongs to the Special Issue Diagnosis and Treatment of Endometrial Cancer)
Expression Analysis of COPB2 and Bcl-2 in Early Stages of Endometrial Carcinoma
Clin. Exp. Obstet. Gynecol. 2023, 50(12), 254; https://doi.org/10.31083/j.ceog5012254
(This article belongs to the Special Issue Diagnosis and Treatment of Endometrial Cancer)
Does Closed Incision Negative Pressure Wound Therapy Reduce Surgical Site Infection in Endometrial Carcinoma Patients Undergoing Laparotomy? A Multicentre Retrospective Cohort Study
Clin. Exp. Obstet. Gynecol. 2023, 50(5), 102; https://doi.org/10.31083/j.ceog5005102
(This article belongs to the Special Issue Diagnosis and Treatment of Endometrial Cancer)
Preoperative Evaluation of 3D-MRI on the Depth of Myometrial Invasion of Endometrial Carcinoma: 3D Study of Endometrial Carcinoma
Clin. Exp. Obstet. Gynecol. 2022, 49(10), 222; https://doi.org/10.31083/j.ceog4910222
(This article belongs to the Special Issue Diagnosis and Treatment of Endometrial Cancer)